These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37865292)

  • 1. Analytical Performance Evaluation of a 523-Gene Circulating Tumor DNA Assay for Next-Generation Sequencing-Based Comprehensive Tumor Profiling in Liquid Biopsy Samples.
    Harter J; Buth E; Johaenning J; Battke F; Kopp M; Zelba H; Schulze M; Koedding J; Biskup S
    J Mol Diagn; 2024 Jan; 26(1):61-72. PubMed ID: 37865292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical and Clinical Validation of a Highly Sensitive NGS-Based ctDNA Assay with Real-World Concordance in Non-Small Cell Lung Cancer.
    Yi H; Youk J; Lim Y; Roh H; Kyung D; Kim HP; Bang D; Keam B; Kim TM; Kim M; Kim DW; Kim TY
    Cancer Res Treat; 2024 Jul; 56(3):765-773. PubMed ID: 38186238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical performance evaluation of a commercial next generation sequencing liquid biopsy platform using plasma ctDNA, reference standards, and synthetic serial dilution samples derived from normal plasma.
    Verma S; Moore MW; Ringler R; Ghosal A; Horvath K; Naef T; Anvari S; Cotter PD; Gunn S
    BMC Cancer; 2020 Oct; 20(1):945. PubMed ID: 33004033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program.
    Park S; Olsen S; Ku BM; Lee MS; Jung HA; Sun JM; Lee SH; Ahn JS; Park K; Choi YL; Ahn MJ
    Cancer; 2021 Aug; 127(16):3019-3028. PubMed ID: 33826761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized Cancer Monitoring Assay for the Detection of ctDNA in Patients with Solid Tumors.
    Zhao J; Reuther J; Scozzaro K; Hawley M; Metzger E; Emery M; Chen I; Barbosa M; Johnson L; O'Connor A; Washburn M; Hartje L; Reckase E; Johnson V; Zhang Y; Westheimer E; O'Callaghan W; Malani N; Chesh A; Moreau M; Daber R
    Mol Diagn Ther; 2023 Nov; 27(6):753-768. PubMed ID: 37632661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical and clinical validation of a novel amplicon-based NGS assay for the evaluation of circulating tumor DNA in metastatic colorectal cancer patients.
    Wang B; Wu S; Huang F; Shen M; Jiang H; Yu Y; Yu Q; Yang Y; Zhao Y; Zhou Y; Pan B; Liu T; Guo W
    Clin Chem Lab Med; 2019 Sep; 57(10):1501-1510. PubMed ID: 31339850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of ctDNA Quality Control Materials Through a Precompetitive Collaboration of the Foundation for the National Institutes of Health.
    Williams PM; Forbes T; P Lund S; Cole KD; He HJ; Karlovich C; Paweletz CP; Stetson D; Yee LM; Connors DE; Keating SM; Destenaves B; Cleveland MH; Lau CJ; Barrett JC; Kelloff GJ; McCormack RT
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34250423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the efficacy of an innovative diagnostic method for identifying 5 % variants in somatic ctDNA.
    Mareso C; Crosta L; De Vita MG; Cristofoli F; Tanzi B; Benedetti S; Bonetti G; Donofrio CA; Cominetti M; Riccio L; Fioravanti A; Generali D; Lucci Cordisco E; Chiurazzi P; Gatta V; Stuppia L; Cecchin S; Bertelli M; Marceddu G
    Gene; 2024 Nov; 928():148771. PubMed ID: 39032702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-generation sequencing for tumor mutation quantification using liquid biopsies.
    Provencio M; Pérez-Barrios C; Barquin M; Calvo V; Franco F; Sánchez E; Sánchez R; Marsden D; Cristóbal Sánchez J; Martin Acosta P; Laza-Briviesca R; Cruz-Bermúdez A; Romero A
    Clin Chem Lab Med; 2020 Jan; 58(2):306-313. PubMed ID: 31469650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of genomic alterations between tumor tissue and circulating tumor DNA by next-generation sequencing.
    Chang YS; Fang HY; Hung YC; Ke TW; Chang CM; Liu TY; Chen YC; Chao DS; Huang HY; Chang JG
    J Cancer Res Clin Oncol; 2018 Nov; 144(11):2167-2175. PubMed ID: 30203147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic profiling of NGS-based ctDNA from Chinese non-small cell lung cancer patients.
    Xi Y; Bai Z; Gao S; Guo J; Zhang Z; Zhang H; Qu L; Xu B; Wang W; Shan G; Cui W; Bai W; Ji X
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8573-8580. PubMed ID: 37186065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical and Clinical Validation of Cell-Free Circulating Tumor DNA Assay for the Estimation of Tumor Mutational Burden.
    Lee KS; Seo J; Lee CK; Shin S; Choi Z; Min S; Yang JH; Kwon WS; Yun W; Park MR; Choi JR; Chung HC; Lee ST; Rha SY
    Clin Chem; 2022 Dec; 68(12):1519-1528. PubMed ID: 36306340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a next-generation sequencing assay for the detection of EGFR mutations in cell-free circulating tumor DNA.
    Stitz R; Buder A; Silye R; Baumgartner B; Pühringer F; Filipits M; Oberndorfer E; Heitzer E
    Exp Mol Pathol; 2021 Dec; 123():104685. PubMed ID: 34560086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing.
    Al Zoughbi W; Fox J; Beg S; Papp E; Hissong E; Ohara K; Keefer L; Sigouros M; Kane T; Bockelman D; Nichol D; Patchell E; Bareja R; Karandikar A; Alnajar H; Cerqueira G; Guthrie VB; Verner E; Manohar J; Greco N; Wilkes D; Tagawa S; Malbari MS; Holcomb K; Eng KW; Shah M; Altorki NK; Sboner A; Nanus D; Faltas B; Sternberg CN; Simmons J; Houvras Y; Molina AM; Angiuoli S; Elemento O; Mosquera JM
    Oncologist; 2021 Nov; 26(11):e1971-e1981. PubMed ID: 34286887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary Molecular Pathology for Patients with Newly Diagnosed Urothelial Bladder Cancer.
    Zhang R; Zang J; Xie F; Zhang Y; Wang Y; Jing Y; Zhang Y; Chen Z; Shahatiaili A; Cai MC; Zhao Z; Du P; Jia S; Zhuang G; Chen H
    J Urol; 2021 Oct; 206(4):873-884. PubMed ID: 34061567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multilaboratory Assessment of a New Reference Material for Quality Assurance of Cell-Free Tumor DNA Measurements.
    He HJ; Stein EV; Konigshofer Y; Forbes T; Tomson FL; Garlick R; Yamada E; Godfrey T; Abe T; Tamura K; Borges M; Goggins M; Elmore S; Gulley ML; Larson JL; Ringel L; Haynes BC; Karlovich C; Williams PM; Garnett A; Ståhlberg A; Filges S; Sorbara L; Young MR; Srivastava S; Cole KD
    J Mol Diagn; 2019 Jul; 21(4):658-676. PubMed ID: 31055023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical and clinical validation of an amplicon-based next generation sequencing assay for ultrasensitive detection of circulating tumor DNA.
    Poh J; Ngeow KC; Pek M; Tan KH; Lim JS; Chen H; Ong CK; Lim JQ; Lim ST; Lim CM; Goh BC; Choudhury Y
    PLoS One; 2022; 17(4):e0267389. PubMed ID: 35486650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid Biopsy Hotspot Variant Assays: Analytical Validation for Application in Residual Disease Detection and Treatment Monitoring.
    Hallermayr A; Benet-Pagès A; Steinke-Lange V; Mansmann U; Rentsch M; Holinski-Feder E; Pickl JMA
    Clin Chem; 2021 Nov; 67(11):1483-1491. PubMed ID: 34392332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct comparison of circulating tumor DNA sequencing assays with targeted large gene panels.
    Yu L; Lopez G; Rassa J; Wang Y; Basavanhally T; Browne A; Huang CP; Dorsey L; Jen J; Hersey S
    PLoS One; 2022; 17(4):e0266889. PubMed ID: 35482763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA.
    Gale D; Lawson ARJ; Howarth K; Madi M; Durham B; Smalley S; Calaway J; Blais S; Jones G; Clark J; Dimitrov P; Pugh M; Woodhouse S; Epstein M; Fernandez-Gonzalez A; Whale AS; Huggett JF; Foy CA; Jones GM; Raveh-Amit H; Schmitt K; Devonshire A; Green E; Forshew T; Plagnol V; Rosenfeld N
    PLoS One; 2018; 13(3):e0194630. PubMed ID: 29547634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.